Deoxycytidine Kinase (DCK) Peptide
Aperçu rapide pour Deoxycytidine Kinase (DCK) Peptide (ABIN936955)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- ATPETCLHRI YLRGRNEEQG IPLEYLEKLH YKHESWLLHR TLKTNFDYLQ
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DCK antibody,
Alternative Names: DCK control peptide, DCK antibody Blocking Peptide, Anti-DCK Blocking Peptide, Deoxycytidine Kinase Blocking Peptide, MGC117410 Blocking Peptide, MGC138632 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- DCK (Deoxycytidine Kinase (DCK))
-
Sujet
- Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.
-
Poids moléculaire
- 30 kDa
Antigène
-